Cogent Biosciences

NASDAQ:COGT
Develops targeted therapies for oncology.
Develops targeted therapies for oncology.

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, MA

Initial Investment

2014
Cogent Biosciences

Cogent Biosciences (NASDAQ:COGT) (formerly Unum Therapeutics) is developing precision therapies for genetically defined diseases with a clinical stage therapy for systemic mastocytosis.